Incyte

-$0.50 (-0.65%) Today
+$0.01 (+0.01%) As of 8:01 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib).

CEO
Herve Hoppenot
Employees
2,094
Headquarters
Wilmington, Delaware
Founded
1991

INCY Key Statistics

Market cap
16.84B
Price-Earnings ratio
18.21
Dividend yield
—
Average volume
1.24M
High today
$77.62
Low today
$75.85
Open price
$76.86
Volume
837.18K
52 Week high
$88.26
52 Week low
$61.91

INCY News

BenzingaMay 20

CHMP Backs Approval of Lilly/Incyte's Olumiant For Patchy Hair Loss

by The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Eli Lilly And Co LLY and Incyt
MarketWatchMay 20

Lilly and Incyte's Olumiant Gets CHMP Recommendation in Alopecia Areata - MarketWatch

By Michael Dabaie Eli Lilly & Co. and Incyte Corp. said the European Medicines Agency's Committee for Medicinal Products for Human Use issued a positive opinio

INCY Earnings

$0.00
$0.39
$0.79
$1.18
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure